MedTrace Logo

Trial of an Online Spanish Pivotal Response Treatment Training in Autism Spectrum Disorder

NCT06690255 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2026-04-29

No results posted yet for this study

Summary

The goal of this clinical trial is to understand if an online course in Spanish can help Spanish-speaking parents use Pivotal Response Treatment (PRT) to support language and social skills in young children with Autism Spectrum Disorder (ASD). This study aims to reach families who may have trouble accessing autism services due to language, location, or cost barriers. The main questions it hopes to answer are:

* Can Spanish-speaking parents learn to effectively use PRT techniques to support their child's communication?
* Does this training improve children's language and social interactions?

Researchers will evaluate the effectiveness of the online course for parents who participate in regular virtual check-ins and submit videos showing their practice with PRT.

Participants in the study will:

* Complete online lessons over 12 weeks that teach PRT methods, specifically designed for Spanish-speaking parents
* Meet with a research team member every few weeks by phone or video to ask questions and receive feedback
* Provide video recordings of interactions with their child to track progress
* Complete brief surveys about their experience and child's communication abilities

By focusing on Spanish-speaking families, this study aims to increase access to effective autism support and reduce gaps in care. Researchers hope the findings will help develop better resources for families facing similar barriers and improve language and social outcomes for children with autism.

Conditions

Interventions

BEHAVIORAL

Pivotal Response Treatment

PRT will target functional communication abilities

Sponsors & Collaborators

Principal Investigators

  • Grace Gengoux, Ph.D. · Stanford University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
2 Years
Max Age
5 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-06-30
Primary Completion
2029-12-15
Completion
2030-12-15

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06690255 on ClinicalTrials.gov